(Q73061703)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

Lei Bao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Urban Lindgren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Y u Zhu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Hans-Gustaf Ljunggren

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Jie Zhu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Neurobiology of Disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

73-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

The critical role of IL-12p40 in initiating, enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Severe inflammatory arthritis and lymphadenopathy in the absence of TNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Tumour necrosis factor-alpha and other cytokines in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Pathogenesis of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Expression of TNFalpha and TGFbeta1 in Guillain-Barré syndrome: correlation of a low TNFalpha-/TGFbeta1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Shedding of tumor necrosis factor receptors by activated human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

1 reference

7 January 2021

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

The pathophysiology of tumor necrosis factors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

P0 protein peptide 180-199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2802%2900007-4

7 January 2021

10.1016/S0969-9961(02)00007-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12609491%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference